|
"toi m"的相關文件
顯示項目 11-17 / 17 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2020-02 |
Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in pat
|
Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pienkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, R;Viale, G;Thomssen, C |
| 臺大學術典藏 |
2018 |
Reply to 'the St Gallen international expert consensus on the primary therapy of early breast cancer 2017: Te point of view of an international panel of experts in radiation oncology' by Kirova et al.
|
on behalf of the Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017; Xu B.; Whelan T.J.; Bonnefoi H.; Brucker S.Y.; Cardoso F.; Carey L.; Ciruelos E.; Cuzick J.; Denkert C.; Di Leo A.; Ejlertsen B.; Francis P.; Galimberti V.; Garber J.; Gulluoglu B.; Goodwin P.; Harbeck N.; Hayes D.F.; CHIUN-SHENG HUANG; Huober J.; Khaled H.; Jassem J.; Jiang Z.; Karlsson P.; Morrow M.; Orecchia R.; Osborne K.C.; Pagani O.; Partridge A.H.; Pritchard K.; Ro J.; Rutgers E.J.T.; Sedlmayer F.; Semiglazov V.; Shao Z.; Smith I.; Toi M.; Tutt A.; Viale G.; Watanabe T.; Bergh J.; Baselga J.; Thrlimann B.; Andr? F.; Senn H.-J.; Piccart-Gebhart M.; Regan M.M.; Colleoni M.; Loibl S.; Gnant M.; Winer E.P.; Burstein H.J.; Curigliano G.; Dubsky P.; Dubsky P.;Curigliano G.;Burstein H.J.;Winer E.P.;Gnant M.;Loibl S.;Colleoni M.;Regan M.M.;Piccart-Gebhart M.;Senn H.-J.;Thrlimann B.;Andr? F.;Baselga J.;Bergh J.;Bonnefoi H.;Brucker S.Y.;Cardoso F.;Carey L.;Ciruelos E.;Cuzick J.;Denkert C.;Di Leo A.;Ejlertsen B.;Francis P.;Galimberti V.;Garber J.;Gulluoglu B.;Goodwin P.;Harbeck N.;Hayes D.F.;Chiun-Sheng Huang;Huober J.;Khaled H.;Jassem J.;Jiang Z.;Karlsson P.;Morrow M.;Orecchia R.;Osborne K.C.;Pagani O.;Partridge A.H.;Pritchard K.;Ro J.;Rutgers E.J.T.;Sedlmayer F.;Semiglazov V.;Shao Z.;Smith I.;Toi M.;Tutt A.;Viale G.;Watanabe T.;Whelan T.J.;Xu B.;On Behalf Of The Panel Members Of The St Gallen International Expert Consensus On The Primary Therapy Of Early Breast Cancer 2017 |
| 臺大學術典藏 |
2017 |
Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients
|
Toi M.; Gl?ck S.; Loo W.T.Y.; Chow C.Y.C.; Zhu L.; Lu Y.S.; CHIUN-SHENG HUANG; Patel J.; Chow L.W.C.;Biganzoli L.;Leo A.D.;Kuroi K.;Han H.S.;Patel J.;Chiun-Sheng Huang;Lu Y.S.;Zhu L.;Chow C.Y.C.;Loo W.T.Y.;Gl?Ck S.;Toi M.; Chow L.W.C.; Biganzoli L.; Leo A.D.; Kuroi K.; Han H.S. |
| 臺大學術典藏 |
2015 |
Personalization of loco-regional care for primary breast cancer patients (part 2)
|
Klimberg V.S.; Noh D.Y.; Krop I.E.; Han W.; Noguchi S.; Pegram M.D.; Yamauchi H.; Lee E.-S.; Larionov A.A.; Bevilacqua J.L.; Yoshimura M.; Sugie T.; Yamauchi A.; CHIUN-SHENG HUANG; Ho A.Y.; Yamauchi C.; Chow L.W.; Kunkler I.; Sasano H.; Benson J.R.; Winer E.P.; Toi M.; Toi M.;Winer E.P.;Benson J.R.;Inamoto T.;Forbes J.F.;Von Minckwitz G.;Robertson J.F.;Grobmyer S.R.;Jatoi I.;Sasano H.;Kunkler I.;Ho A.Y.;Yamauchi C.;Chow L.W.;Chiun-Sheng Huang;Han W.;Noguchi S.;Pegram M.D.;Yamauchi H.;Lee E.-S.;Larionov A.A.;Bevilacqua J.L.;Yoshimura M.;Sugie T.;Yamauchi A.;Krop I.E.;Noh D.Y.;Klimberg V.S.; Jatoi I.; Grobmyer S.R.; Robertson J.F.; Von Minckwitz G.; Inamoto T.; Forbes J.F. |
| 國立臺灣大學 |
2014 |
TOXICITY PROFILES OF ADJUVANT DOCETAXEL-CYCLOPHOSPHAMIDE IN ASIAN COMPARED WITH CAUCASIAN PATIENTS WITH BREAST CANCER
|
Chow, L. W. C.; Biganzoli, L.; Di Leo, A.; Kuroi, K.; Han, H. S.; Patel, J.; Huang, C. S.; Lu, Y. S.; Zhu, L.; Yip, A. Y. S.; Glueck, S.; Toi, M.; 盧彥伸; 黃俊升 |
| 臺大學術典藏 |
2012 |
Preoperative systemic therapy in locoregional management of early breast cancer: Highlights from the Kyoto Breast Cancer Consensus Conference
|
Toi M.; Benson J.R.; Winer E.P.; Forbes J.F.; Von Minckwitz G.; Golshan M.; Robertson J.F.R.; Sasano H.; Cole B.F.; Chow L.W.C.; Pegram M.D.; Han W.; CHIUN-SHENG HUANG; Ikeda T.; Inamoto T.; Kanao S.; Lee E.-S.; Noguchi S.; Ohno S.; Partridge A.H.; Rouzier R.; Tozaki M.; Sugie T.; Yamauchi A. |
| 國家衛生研究院 |
2010-07 |
Longer-term assessment of trastuzumab-related cardiac adverse events in the herceptin adjuvant (HERA) trial
|
Procter, M;Suter, TM;de Azambuja, E;Dafni, U;van Dooren, V;Muehlbauer, S;Climent, MA;Rechberger, E;Liu, TW;Toi, M;Coombes, RC;Dodwell, D;Pagani, O;Madrid, J;Hall, M;Chen, SC;Focan, C;Muschol, M;van Veldhuisen, DJ;Piccart-Gebhart, MJ |
顯示項目 11-17 / 17 (共1頁)
1
每頁顯示[10|25|50]項目
|
